Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1228945.RAq0s2zMtmOSiovzOPqMr72LN1XiRVUEG8P7cuXL3V-Y0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1228945.RAq0s2zMtmOSiovzOPqMr72LN1XiRVUEG8P7cuXL3V-Y0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1228945.RAq0s2zMtmOSiovzOPqMr72LN1XiRVUEG8P7cuXL3V-Y0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1228945.RAq0s2zMtmOSiovzOPqMr72LN1XiRVUEG8P7cuXL3V-Y0130_provenance.
- NP1228945.RAq0s2zMtmOSiovzOPqMr72LN1XiRVUEG8P7cuXL3V-Y0130_assertion description "[Throughout the treatment, SNV promoted the expression of the anti-inflammatory cytokine interleukin-10 as well as neurotrophic factors commonly considered as beneficial in amyotrophic lateral sclerosis management (glial derived neuroptrophic factor, insulin like growth factor, brain derived neurotrophic factor).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1228945.RAq0s2zMtmOSiovzOPqMr72LN1XiRVUEG8P7cuXL3V-Y0130_provenance.
- NP1228945.RAq0s2zMtmOSiovzOPqMr72LN1XiRVUEG8P7cuXL3V-Y0130_assertion evidence source_evidence_literature NP1228945.RAq0s2zMtmOSiovzOPqMr72LN1XiRVUEG8P7cuXL3V-Y0130_provenance.
- NP1228945.RAq0s2zMtmOSiovzOPqMr72LN1XiRVUEG8P7cuXL3V-Y0130_assertion SIO_000772 25311268 NP1228945.RAq0s2zMtmOSiovzOPqMr72LN1XiRVUEG8P7cuXL3V-Y0130_provenance.
- NP1228945.RAq0s2zMtmOSiovzOPqMr72LN1XiRVUEG8P7cuXL3V-Y0130_assertion wasDerivedFrom befree-2016 NP1228945.RAq0s2zMtmOSiovzOPqMr72LN1XiRVUEG8P7cuXL3V-Y0130_provenance.
- NP1228945.RAq0s2zMtmOSiovzOPqMr72LN1XiRVUEG8P7cuXL3V-Y0130_assertion wasGeneratedBy ECO_0000203 NP1228945.RAq0s2zMtmOSiovzOPqMr72LN1XiRVUEG8P7cuXL3V-Y0130_provenance.
- befree-2016 importedOn "2016-02-19" NP1228945.RAq0s2zMtmOSiovzOPqMr72LN1XiRVUEG8P7cuXL3V-Y0130_provenance.